Feature Channels:

Women's Health

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Fertility, Miscarriage, Cells, Natural Killer Cells

Womb Natural Killer Cell Discovery Could Lead to Screening for Miscarriage Risk

imagefromahumanembryoculturedwithdecidualcellsinthelab..jpg

For the first time the functions of natural killer cells in the womb have been identified.

Medicine

Channels:

cancer advances, Breast Cancer, Gene, Genetic Variation, SNPs, Early Onset, Women's Health

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 14-Dec-2017 7:00 PM EST

Medicine

Channels:

Breast Cancer, Surgery, American College Of Surgeons

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 15-Dec-2017 11:00 AM EST

Life

Arts and Humanities

Channels:

the Mount Sinai Health System, Icahn School of Medicine at Mount Sinai, Dubin Breast Center, Tisch Cancer Institute, Kara DioGuardi, Immunotherapy, Breast Cancer

Sixth Annual Benefit Raises More Than $3.4 Million for the Dubin Breast Center

13.jpg

The Dubin Breast Center of The Tisch Cancer Institute at the Mount Sinai Health System held its sixth annual benefit on Monday, December 11, 2017, at the Ziegfeld Ballroom in Manhattan.

Science

Channels:

UCLA Study Finds Link Between Breast Cancer Treatments and Cellular Markers of Aging

CarrollJudith.jpg

A new study has found that women who had received chemotherapy and/or radiation to treat breast cancer were more likely to have high levels of DNA damage and reduced activity of an enzyme involved in chromosome healing, compared to women who underwent surgery alone. The results suggest that some breast cancer survivors may be more vulnerable to biological changes associated with accelerated aging because of their prior treatment.

Medicine

Channels:

Gene Editing, Gene Therapy, Center for Individualized Medicine, Genetic Engineering

Mayo Clinic Bioethicist Megan Allyse, ph.d., Discusses 4 Key Things to Know About the Possibilities, Pitfalls of Gene Editing

Gene editing has captivated scientists and medical providers with tantalizing visions of wiping out debilitating inherited diseases.

Medicine

Channels:

Nitric Oxide, CVD-preventive measures, CVD, Women's Health, Nathan Bryan, Ph.D., Felice Gersh, Ernst Schwarz, David Lefer, Age-related Diseases, Anti-aging medicine, nitric oxide function, Cardiovacular Disease, post-menopausal women, cognitive health, Sexual Function, Eriticle , eritile dysfunction, Hypertension, A4M Annual World Congress

Clinicians Who Ignore Nitric Oxide (NO) Function Put Their Patients at Risk

Dr. Nathan Bryan, Baylor College of Medicine and one of the leading experts in nitric oxide biochemistry and physiology said today, “healthcare providers, especially those helping patients with cardiovascular issues and age-related disease, are not using perhaps the most important ‘tool’ in their ‘toolbox,’ restoring nitric oxide function. Bryan organized and chaired a full day workshop on the Clinical Applications of Nitric Oxide held during the 25th American Academy of Anti-Aging Medicine World Congress.

Medicine

Channels:

Bioethics, Ethics, fetal therapy , Jeremy Sugarman

Bioethicists Call for Caution in Use of Rare Experimental Fetal Therapy

Pregnant_Woman_Baby_iStock-841956208.jpg

Citing uncertainties about the risks and benefits of an experimental therapy for fetuses whose kidneys do not develop, bioethicists at Johns Hopkins and a team of medical experts are calling for rigorous clinical trials in the use of a potential treatment, known as amnioinfusion.

Medicine

Channels:

Breast Cancer, Side Effect, Tamoxifen, Aromatase Inhibitor

Soy, Cruciferous Vegetables Associated with Fewer Common Side Effects of Breast Cancer Treatment

Cruciferous.jpg

Consuming soy foods (such as soy milk, tofu and edamame) and cruciferous vegetables (such as cabbages, kale, collard greens, bok choy, Brussels sprouts, and broccoli) may be associated with a reduction in common side effects of breast cancer treatment in breast cancer survivors, say a team of scientists.

Medicine

Channels:

Penn Medicine, Perelman School of Medicine at the University of Pennsylvania, San Antonio Breast Symposium, Breast Cancer, PARP inhibitor, basser center for brca, abramson cancer center

New Mediola and OlympiAD Trial Results Offer Another Boon for PARP Inhibitors in Treatment of Advanced BRCA-Related Breast Cancer

Patients with certain advanced hereditary breast cancers may have new treatments options on the horizon, according to two studies presented this week at the annual San Antonio Breast Cancer Symposium. Susan Domchek, MD, executive director of the Basser Center for BRCA at Penn’s Abramson Cancer Center, will present new results from the Mediola and OlympiAD trials showing continued success of treating BRCA-related metastatic breast cancer with the PARP inhibitor olaparib with limited side effects for patients.







Chat now!